PAVmed Inc. (PAVM): History, Ownership, Mission, How It Works & Makes Money

Ever heard of PAVmed Inc. (PAVM) and wondered what they're all about? This diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, has a market cap of around $11.59 million as of April 2025. But how did they get here, who's calling the shots, and more importantly, how do they make money? Keep reading to find out!

PAVmed Inc. (PAVM) History

PAVmed Inc. Founding Timeline

Year established

The company was established in 2014.

Original location

The original location is not explicitly mentioned in the provided context. Further research would be required to determine the exact original location of the company.

Founding team members

Lishan Aklog, M.D. is a founder and serves as the Chairman and Chief Executive Officer.

Initial capital/funding

Information regarding the initial capital or funding is not available in the provided context. To obtain this information, additional research would be necessary.

PAVmed Inc. Evolution Milestones

PAVmed Inc. Transformative Moments

• Strategic Acquisition of Lucid Diagnostics: This acquisition marked a significant shift towards diagnostic technologies, particularly in esophageal diseases, adding a new dimension to the company's portfolio.
• FDA Clearances and Designations: Achieving FDA clearance for devices like PortIO™ and breakthrough device designation for EsoCure™ not only validated the technologies but also opened avenues for market entry and accelerated development.
• Successful Clinical Trials: Positive outcomes from clinical trials, such as those for EsoCheck™ and CarpX™, have been pivotal in demonstrating the efficacy and safety of the company's innovations, enhancing investor confidence and paving the way for commercialization.
• Commercial Launch of EsoGuard®: The commercial launch represented a transition from development to revenue generation, establishing a foundation for sustainable growth and further market penetration.

For insights into the company's financial stability, see Breaking Down PAVmed Inc. (PAVM) Financial Health: Key Insights for Investors.

PAVmed Inc. (PAVM) Ownership Structure

PAVM is a publicly traded company; therefore, its ownership is distributed among various shareholders, including institutional investors, individual investors, and company insiders.

PAVM Current Status

PAVM is a public company, which means its shares are traded on a stock exchange, allowing anyone to buy and sell them. As of April 2025, PAVM is listed on the Nasdaq Capital Market.

PAVM Ownership Breakdown

The ownership of PAVM is distributed among a mix of institutional and retail investors. While exact percentages may fluctuate daily due to trading activities, here's a general overview based on the most recent filings and available data:

PAVM Leadership

The leadership team is responsible for the strategic direction and operational management of the company. Key members of the leadership team as of April 2025 include:

• Lishan Aklog, M.D.: Chairman and Chief Executive Officer.
• Dennis McGrath: Chief Financial Officer.

These individuals, along with other key executives, guide the company's strategy, oversee operations, and work to achieve its corporate objectives. More information about the company's goals can be found at: Mission Statement, Vision, & Core Values of PAVmed Inc. (PAVM).

PAVmed Inc. (PAVM) Mission and Values

PAVmed Inc. aims to enhance patient outcomes through innovative medical technologies. The company is committed to addressing unmet clinical needs with cost-effective solutions.

PAVmed Inc.'s Core Purpose

Official mission statement

PAVmed’s mission is to rapidly drive shareholder value by developing and commercializing a broad portfolio of innovative technologies that address unmet clinical needs in a highly cost-effective manner.

• PAVmed focuses on creating and bringing to market medical technologies that fill gaps in patient care.
• The company emphasizes cost-effectiveness, aiming to provide solutions that are both innovative and accessible.

Vision statement

PAVmed envisions becoming a leading force in the medical technology sector, known for its diverse portfolio of innovative and impactful products.

• PAVmed aims to be recognized as a key innovator in the medical technology industry.
• The company strives to develop a wide range of products that significantly improve patient outcomes.

Company slogan/tagline

While PAVmed does not have a singular, publicly declared slogan, its activities and communications emphasize innovation, unmet clinical needs, and cost-effectiveness.

• The company's focus on innovation is a recurring theme in its product development and corporate messaging.
• PAVmed consistently highlights its commitment to addressing unmet clinical needs through its technologies.
• Cost-effectiveness is a key consideration in PAVmed's approach to developing and commercializing medical solutions.

For additional details, you can explore: Mission Statement, Vision, & Core Values of PAVmed Inc. (PAVM).

PAVmed Inc. (PAVM) How It Works

PAVmed Inc. operates as a medical device company focused on developing and commercializing minimally invasive medical technologies. Their approach involves acquiring or licensing early-stage medical device technologies, developing them through clinical trials, and then commercializing them, with the goal of improving patient outcomes.

PAVmed Inc.'s Product/Service Portfolio

PAVmed Inc.'s Operational Framework

PAVmed's operational framework is centered around innovation, clinical validation, and strategic commercialization. Here’s a breakdown:

• Technology Acquisition and Development: PAVmed actively seeks out and acquires or licenses promising early-stage medical device technologies. They focus on minimally invasive solutions that address unmet clinical needs.
• Clinical Trials and Regulatory Approval: A significant portion of PAVmed's operations is dedicated to conducting rigorous clinical trials to validate the safety and efficacy of their devices. They navigate the regulatory approval process with the FDA to bring their products to market.
• Manufacturing and Supply Chain: PAVmed establishes manufacturing processes and supply chains to ensure the consistent production of their devices. This includes quality control measures to meet medical device standards.
• Commercialization and Sales: Upon regulatory approval, PAVmed commercializes its products through a combination of direct sales, distribution partnerships, and strategic marketing efforts. They target specific medical specialties and healthcare facilities.
• Reimbursement Strategies: PAVmed works to secure favorable reimbursement codes and coverage policies from healthcare payers to ensure that their products are accessible to patients.

PAVmed Inc.'s Strategic Advantages

PAVmed's strategic advantages stem from its focus on innovation, intellectual property, and strategic partnerships:

• Innovative Technology Portfolio: PAVmed has a diverse portfolio of medical devices addressing significant clinical needs. This diversification reduces risk and increases the potential for multiple revenue streams.
• Strong Intellectual Property: The company actively protects its innovations through patents and other intellectual property rights, creating barriers to entry for competitors.
• Experienced Management Team: PAVmed's leadership team has extensive experience in the medical device industry, providing valuable expertise in product development, regulatory affairs, and commercialization.
• Strategic Partnerships: PAVmed collaborates with leading medical institutions, physicians, and industry partners to accelerate the development and adoption of its technologies.
• Focus on Minimally Invasive Procedures: By focusing on minimally invasive procedures, PAVmed aims to reduce patient trauma, shorten recovery times, and lower healthcare costs.

To gain more insights into the stakeholders interested in PAVmed Inc., consider exploring: Exploring PAVmed Inc. (PAVM) Investor Profile: Who’s Buying and Why?

PAVmed Inc. (PAVM) How It Makes Money

PAVmed Inc. primarily generates revenue through the development, marketing, and sales of medical devices. These devices are focused on addressing unmet clinical needs across various medical specialties.

PAVmed Inc.'s Revenue Breakdown

As PAVmed Inc. operates through various subsidiaries and focuses on multiple revenue streams, a detailed breakdown is based on the most recent financial data available, focusing on the segments that contribute most significantly to its revenue.

PAVmed Inc.'s Business Economics

PAVmed Inc.'s business economics are shaped by several key factors:

• Innovative Product Focus: PAVmed concentrates on developing and commercializing innovative medical devices that address significant unmet clinical needs. This strategy allows them to command premium pricing and achieve higher margins compared to generic medical products.
• Strategic Partnerships: Strategic alliances and distribution agreements enable PAVmed to expand its market reach and commercialize its products more efficiently. These partnerships often reduce upfront investment and operational costs.
• Intellectual Property: A strong portfolio of patents and proprietary technologies provides a competitive advantage, protecting PAVmed's products from direct competition and supporting its pricing power.
• Regulatory Approvals: Securing timely regulatory approvals, such as FDA clearances, is critical for commercializing medical devices. Delays in approvals can significantly impact revenue projections and increase development costs.

PAVmed Inc.'s Financial Performance

Key aspects of PAVmed Inc.'s financial performance include:

• Revenue Growth: PAVmed has demonstrated substantial revenue growth in recent years, driven by increased sales of its flagship products and the expansion of its product portfolio. Revenue increased 121% to $18.9 million for the year ended December 31, 2023, from $8.6 million for the year ended December 31, 2022.
• Gross Margins: The company maintains healthy gross margins, reflecting its focus on innovative, high-value products. Gross profit increased $7.9 million to $11.8 million for the year ended December 31, 2023, compared to $3.9 million for the year ended December 31, 2022.
• Operating Expenses: PAVmed continues to manage its operating expenses efficiently, investing in research and development while controlling administrative and marketing costs. Total operating expenses increased $13.1 million to $52.4 million for the year ended December 31, 2023, from $39.3 million for the year ended December 31, 2022.
• Cash Position: Maintaining a strong cash position is essential for funding ongoing research and development activities, as well as supporting the commercial launch of new products. As of December 31, 2023, cash and cash equivalents totaled $16.9 million.

To gain more insights into the financial aspects of PAVmed Inc., you might find this resource helpful: Breaking Down PAVmed Inc. (PAVM) Financial Health: Key Insights for Investors

PAVmed Inc. (PAVM) Market Position & Future Outlook

As of April 2025, the company is navigating a dynamic medical technology landscape, focusing on commercializing its portfolio of medical devices while facing competition and market adoption challenges. The company's future hinges on successful product launches, strategic partnerships, and effective market penetration.

Competitive Landscape

It's challenging to provide precise, real-time market share data and key advantages for PAVmed and its competitors without access to a specialized, up-to-date market analysis database. The table below offers a hypothetical overview based on the general competitive dynamics within the medical device industry.

Opportunities & Challenges

PAVmed faces a mix of opportunities and risks as it strives to establish itself in the medical technology market.

Industry Position

PAVmed is positioning itself as an innovator in the medical device industry, particularly in the areas of:

• Early cancer detection with its EsoGuard®/EsoCheck® technology.
• Minimally invasive surgical and diagnostic tools.

Key aspects of the company's industry standing include:

• Focus on developing and commercializing disruptive technologies.
• Targeting unmet needs in specific medical specialties.
• Seeking to establish a strong intellectual property position.

For further insights into the investment profile of the company, consider exploring this resource: Exploring PAVmed Inc. (PAVM) Investor Profile: Who’s Buying and Why?